Gilead, Feds Resolve HIV Drug Patent Dispute Amid Appeal <https://www.law360.com/delaware/articles/2284865?nl_pk=9f0ef0c6-df48-47ce-8c94-4f68ac959c6f&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2025-01-16&read_main=1&nlsidx=0&nlaidx=1> By Hailey Konnath Gilead Sciences and the federal government have agreed to dismiss all claims and counterclaims in a yearslong intellectual property and contract battle over HIV prevention drugs Truvada and Descovy, according to stipulations of voluntary dismissal filed Wednesday in both the Federal Circuit and Delaware federal court. 2 documents attached | Read full article » <https://www.law360.com/delaware/articles/2284865?nl_pk=9f0ef0c6-df48-47ce-8c94-4f68ac959c6f&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2025-01-16&read_more=1&nlsidx=0&nlaidx=1> | Save to favorites » <https://www.law360.com/delaware/articles/2284865?nl_pk=9f0ef0c6-df48-47ce-8c94-4f68ac959c6f&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2025-01-16&read_later=1&nlsidx=0&nlaidx=1>